Redeye provides a short note following another order announcement from Scandinavian ChemoTech earlier this morning. The order amounts to EUR48,000 and comes from a German equine clinic. We had initally planned to await the outcome of the ongoing rights issue before making any valuation changes, but given the recent news flow we believe that a slight increase in fair value range is warranted.